Skip to content
S4677Senate2023-2024 SessionSame asA1969

Study ADHD Meds for Kids

Official title

“Authorizes and directs the department of health to conduct a study on drugs prescribed for school age children with ADD and ADHD”

Sponsor Kevin S. ParkerSD-21+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill directs New York's health department to study the effects and diagnosis practices of ADHD medications in school-age children.

Why it matters

  1. Potential impact on prescribing practices. By focusing on the side effects and appropriateness of medications for ADD/ADHD in children, the study could lead to changes in how these drugs are prescribed, potentially resulting in new guidelines that prioritize safety and effectiveness.

  2. Addressing diagnostic equity. The required investigation into demographic disparities means the study could uncover whether certain groups of children are over- or under-diagnosed or over- or under-prescribed, highlighting potential biases or gaps in the mental health system.

  3. Influence on educational and health policy. The involvement of both health and education commissioners suggests findings could drive changes not just in medical protocols but also in school policies regarding the identification and support of students with ADD/ADHD.

  4. Long-term implications for children’s well-being. By mandating a comprehensive review, the bill could pave the way for reforms that better protect children from unnecessary medication, ensure effective treatment, and address broader mental health and developmental concerns.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Study ADHD Meds for Kids

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Kevin S. Parker

Senator · Senate District 21

Chair, Energy And Telecommunications

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A1969Assembly

Study ADHD Drug Effects

In Assembly Committee · Health · Sponsor Latrice Walker

Impact 4 · Low0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4677

2023-2024 Regular Sessions

IN SENATE

February 13, 2023

Introduced by Sen. PARKER -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. 1. The commissioner of health, in conjunction with the commissioner of mental health, the commissioner of developmental disabilities, and the commissioner of education is authorized and directed to conduct a study and do research as to the effect of psychostimulants, selective serotonin reuptake inhibitors, antidepressants and other drugs prescribed for attention deficit disorder, attention deficit hyperactivity disorder, and the increasing rate of diagnosis of these conditions, in school age children.

2. The study shall be conducted in accordance with rules, regulations and standards determined by the commissioner of health, and the study shall concentrate on harmful side effects of such drugs, the appropriateness and effectiveness of tools and methods used to assess and diagnose the condition, the appropriateness of different medications, and any demographic disparities in diagnosis.

3. The commissioner of health shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate on or before two years from the date this act shall take effect.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD05576-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children

Purpose or general idea of the bill

To conduct a study on drugs prescribed for school-age children with ADD and ADHD, making recommendations thereafter.

Summary of specific provisions

Authorizes the commissioner of health, in conjunction with the commis- sioner of mental health, the commissioner of Developmental Disabilities and the commissioner of education to conduct a study and do research as to the effect of psycho stimulants, selective serotonin reuptake inhibi- tors, antidepressants and other drugs prescribed for ADD and ADHD, in school age children. The commissioner shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate within two years that this act shall take effect.

Justification

Currently 5 million school kids in America are on psychotropic drugs. The Centers for Disease Control and Prevention (CDC) looked at drug overdose deaths among children ages 15 to 19 over a 16-year period, from 1999 to 2015, and showed that from 1999 to the mid-2000s drug overdose deaths in this age group more than doubled from 1.6 deaths per 100,000 in 1999 to 4.2 deaths per 100,000 in 2007).

Kids are routinely being misdiagnosed and forced to take drugs for behavior problems, often containing violent side effects. This problem is becoming an epidemic with no end in sight. It is imperative that the commissioner DOH performs a study on the effects of medicating our school children, and making recommendations thereafter.

Prior legislative history

2021-22: S3167- Referred to Health

2019-20: S2599- Referred to Health

2017-18: S2193 - Referred to Health

2015-16: S.2761 - Referred to Health

2013-14: S.3100 - Referred to Health

2011-12: S.1172 - Referred to Health

2009-10: S.8202/A.5602 - Passed Both Houses, Vetoed Memo 6752

2008-09: A.5388 - Passed Assembly 2007-08: A.5388 - Passed Assembly

2006-07: A.5885A - Passed Assembly

2005-06: A.5885 - Health

Effective date

This act shall take effect immediately

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.